Lakewood-Amedex, Inc. Patent Portfolio Summary


Lakewood-Amedex has several families of patents in different technology sectors. However, the Company’s focus is on developing its Bisphosphocin antimicrobials for the treatment of several serious bacterial infection indications where antibiotic-resistant pathogens are particularly prevalent. The Company’s drug candidate for most of these indications is Nu-8, a new member of the Bisphosphocin class. Lakewood-Amedex has recently filed a broad patent application on this compound that if granted will provide protection until at least 2038. The Company has also recently filed a patent application on its proprietary Nu-3 gel formulation, which it intends to use in clinical trials for the treatment of chronic diabetic foot ulcers. If granted, this patent will provide protection until at least 2038.

Patent Family 1

 

Country Title Filing Date Application No. Patent No. Status  
Australia ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 2018230805 N/A Pending
Brazil ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 1120190186158 N/A Pending
Canada ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 3055932 N/A Pending
China ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 201880030624.4

 

 N/A Published
Europe ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 18763136.1

 

 N/A Published
Hong Kong ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 62020007940.3 Pending
India ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 201927040425

 

 N/A Pending
Japan ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 2019-570355

 

 N/A Pending
Korea ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 10-2019-7029037

 

 N/A Published
Mexico ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 MX/a/2019/010695

 

 N/A Pending
New Zealand ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 757711 N/A Pending
United States ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 16/492861 N/A Pending
United States ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 16/505497 N/A Allowed
United States ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 16/505501 N/A Allowed
WO ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 PCT/US2018/022068

 

 N/A Expired
WO ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF 03/12/2018 PCT/US2018/022071

 

 N/A Expired

 

Patent Family 2

 

Country Title Filing Date Application No. Patent No. Status  
Australia BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 2018282905 N/A Pending
Brazil BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 BR112019026073-0 N/A Pending
Canada BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 3066722 N/A Pending
China BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 201880038759.5

 

 N/A Published
Europe BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 18816615.1 N/A Published
Hong Kong BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 18816615.1 N/A Pending
India BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 201927053712

 

 N/A Pending
Japan BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 2019-567981

 

 N/A Pending
Korea BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 1020207000424

 

 N/A Pending
Mexico BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 MX/a/2019/014772

 

 N/A Pending
New Zealand BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 759577

 

 N/A Pending
United States BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF 06/12/2018 16/006,660 N/A Published

 

Patent Family 3

 

Country Title Filing Date Application No. Patent No. Status  
United States METHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS 10/17/2019 16/656,129 N/A Published
United States METHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS 10/17/2019 PCT/US19/56772

 

 N/A Published

 

Patent Family 4

 

Country Title Filing Date Application No. Patent No. Status  
Japan Antimicrobial Compounds And Methods For Their Use 05/03/2002 2009-120362 JP5503900 In Force
Japan Antimicrobial Compounds And Methods For Their Use 05/03/2002 2013-210031 JP5883838 In Force
Japan Protonated/Acidified Nucleic Acids And Methods Of Use 05/03/2002 2015-219286 JP6097372 In Force
United States Antimicrobial And Antiviral Compounds And Methods For Their Use 12/30/1998 11/552951 US7868162 In Force

 

Patent Family 5

 

Country Title Filing Date Application No. Patent No. Status  
United States Oligonucleotide-Containing Pharmacological Compositions And Their Use 07/10/2002 11/673486 US8916529 In Force

 

Patent Family 6

 

Country Title Filing Date Application No. Patent No. Status  
Australia Compositions And Methods For The Treatment Of Muscle Wasting 06/30/2006 2006345724 AU2006345724 In Force
Canada Antisense Oligonucleotide Targeting Myostatin or Fox01 for Treatment of Muscle Wasting 06/30/2006 2558160 CA2558160 In Force
China Compositions And Methods For The Treatment Of Muscle Wasting 06/24/2005

 

 200510077730.2

 

 CN100393320

 

 In Force
United Kingdom Compositions And Methods For The Treatment Of Muscle Wasting 06/30/2006 616790.2 GB2441581 In Force
United States Compositions And Methods For The Treatment Of Muscle Wasting 06/30/2006 11/479112 US8097596 In Force

 

 

Patent Family 7

 

Country Title Filing Date Application No. Patent No. Status  
United States Compositions And Methods For The Treatment Of Influenza Infection 07/18/2006 11/458378 US9574243 In Force
United States Compositions And Methods For The Treatment Of Influenza Infection 07/18/2006 15/400,797

 

 US10378014

 

 In Force